The most common founder I meet is a clinician with a genuinely good insight. They have seen a problem hundreds of times, from closer than any product manager ever will. They know the workaround every colleague uses, the risk everyone tolerates, the twenty minutes lost on every shift. And they have concluded, reasonably, that this insight is the foundation of a company.
It is a foundation. It is not a business model. After mentoring hundreds of clinical entrepreneurs through the NHS Clinical Entrepreneur Programme and MedTech Mentor, I would put this near the top of the list of expensive misunderstandings.
What clinical insight actually buys you
Clinical insight buys you three real advantages. First, problem authenticity: you are far less likely to build something nobody needs, which kills most startups. Second, access and trust: clinicians will talk to you honestly in a way they will not talk to a consultancy. Third, credibility with early adopters, who can tell within minutes whether a founder has ever actually delivered care.
None of these tells you who pays, how much, out of which budget, on what cycle, or why now. None of them tells you whether the person who feels the pain has any purchasing power at all. In healthcare they usually do not: the user is a clinician, the buyer is an organisation, the budget holder is someone you have never met, and the patient, who benefits most, pays nothing. A business model is an answer to that puzzle. Clinical insight is only the clue you start from.
The pattern that follows
The pattern is predictable. The founder builds first, because building feels like progress and validation feels like delay. The product works. Pilots happen, because pilots are easy to say yes to when they are free. Then nothing converts, because nobody worked out early who the economic buyer was and what evidence they would need to justify spending real money. Two years and a lot of goodwill get spent discovering a question that could have been asked in month one.
The questions that turn insight into a model
If you are a clinician founder, these are the questions I would want answered before any serious build. Who is the buyer, as distinct from the user? What budget does this come from, and what does that budget holder get fired for? What evidence would make this an easy yes for them, and what is the cheapest honest way to generate it? What does the sales cycle actually look like, in months, for organisations like the ones you are selling to? And what happens to your economics if adoption takes three times longer than your plan assumes, because in healthcare it usually does?
None of this diminishes the value of clinical insight. It is the reason clinician founders can build things others cannot. But insight earns you the right to start the commercial work, not to skip it.
If you’re an early-stage medtech founder working through exactly this, structured support is available through MedTech Mentor.